Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (2493)	10/26/1997 9:57:00 PM
From: Steve Fancy	of 6136

Mannn, you can't say much on this thread without it being taken out of context. I believe I was the one who persued both of these issues. I believe the insider news is what caused the stock to drop the end of the day Friday, and that raised a concern on my shorter term AGPH investments...like other folks here. I simply posted the data for all to see, and asked for feedback, all of which I appreciate. On the P/E issue, I was simply pointing out that the Fortune article was erroneous, or extremely out of date, and that the stock appeared to be trading at a reasonable P/E when compared with the speculated growth rate. It seems this is not the first article recently describing AGPH as fully valued, and the latest comments appear to be based on bogus numbers. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next